Published on January 18 2024

Launch of a new version of

The Reference Center for Teratogenic Agents is an advice and expertise center concerning the risks of exogenous agents (mainly drugs) on pregnancy, breastfeeding and fertility. The CRAT website ensures the dissemination of the expertise of its multidisciplinary team

Informing healthcare professionals about the risks of drug exposure during pregnancy or breastfeeding, or on fertility (male and female)

The CRAT (Centre de Référence sur les Agents Tératogènes) medical team, led by Benoît Marin, PUPH and member of the PEPITES team at IPLESP, is pleased to announce the forthcoming launch of a new version of its medical information website about the risks associated with exogenous agents (mainly drugs) on fertility (male, female), pregnancy and breastfeeding.

Here are the main changes implemented to provide healthcare professionals with the best possible support in their clinical practice:

- An optimized user experience. The site has been developed using the latest web technology to provide fluid, intuitive navigation.

- Enhanced accessibility. The mobile version of the site has been designed to improve navigation on smartphones and tablets.

- A simplified search function. A central search bar with predictive input has been integrated into the home page. Searches can be made by active substance name, specialty name, drug class or pathology.

- An "individualized" breastfeeding section. Pregnancy and breast-feeding information are now presented separately to facilitate searches and the reading of each content.

Of course, this new version of the CRAT website is still :

- A free, public resource, written by expert professionals with no ties of interest to the pharmaceutical industry.

- Offering reliable, relevant and up-to-date content.

- With information presented in a structured way: "State of the art" and "In practice" sections.